Induction of Apoptosis in Human Leukaemia Cells is Differentially Regulated by Vitamin D Derivatives and Retinoids

References

• Williams, G. T. and Smith, C. A. (1991). Cell, 74, 777–779.
   Web of Science ®Google Scholar
• Lane, D. P. (1992). p53, guardian of the genome. Nature, 358, 15–16.
   PubMed Web of Science ®Google Scholar
• Gottlieb, T. M. and Oren, M. (1996). p53 in Growth Control and Neoplasia. Biochim. et Biophys. Acta, 1287, 77–102.
   PubMed Web of Science ®Google Scholar
• Jacobson, M. D. and Evan, G. I. (1994). Apoptosis: Breaking the ICE. Curr. Biol., 4, 337–340.
   PubMed Web of Science ®Google Scholar
• Cosman, D. (1994). A family of ligands for the TNF receptor superfamily. Stem Cells, 12, 440–455.
   PubMed Web of Science ®Google Scholar
• Yang, E. and Korsmeyer, S. J. (1996). Molecular thanatopsis: a discourse on the bcl-2 family and cell death. Blood, 88, 386–401.
   PubMed Web of Science ®Google Scholar
• Tsujimoto, Y., Gorham, J., Cossman, J., Jaffe, E. and Croce, C. M. (1985). The t(14;18). chromosome translocations involved in B-cell neoplasms result from mistakes in VDJ joining. Science, 229, 1390–1393.
   PubMed Web of Science ®Google Scholar
• Sentman, C. L., Shutter, J. R., Hockenbery, D., Kanagawa, O. and Korsmeyer, S. J. (1991). bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes. Cell, 67, 879–888.
   PubMed Web of Science ®Google Scholar
• Nuñez, G., London, L., Hockenbery, D., Alexander, M., McKearn, J. P. and Korsmeyer, S. J. (1990). Deregulated bcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines. J. Immunol., 144, 3602–3610.
   PubMed Web of Science ®Google Scholar
• Miyashita, T. and Reed, J. C. (1993). bcl-2 oncoprotein blocks chemotherapy induced apoptosis in a human leukemia cell line. Blood, 81, 151–157.
   PubMed Web of Science ®Google Scholar
• Boise, L. H., Gonzalez-Garcia, M., Postema, C. E., Ding, L., Lindsten, T., Turka, L. A., Mao, X., Nuñez, G. and Thompson, C. B. (1993). bcl-2 related gene that functions as a dominant regulator of apoptotic cell death. Cell, 74, 597–608.
   PubMed Web of Science ®Google Scholar
• Hengartner, M. O., Ellis, R. E. and Horvitz, H. R. (1992). Caenorhabditis elegans gene ced-9 protects cells from programmed cell death. Nature, 356, 494–499.
   PubMed Web of Science ®Google Scholar
• Oltvai, Z. N., Milliman, C. L. and Korsmeyer, S. J. (1993). Bcl-2 heterodimerises in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell, 74, 609–619.
   PubMed Web of Science ®Google Scholar
• Yang, E., Zha, J., Jockel, J., Boise, L. H., Thompson, C. B. and Korsmeyer, S. J. (1995). Bad, a heterodimeric partner for Bcl-xL and Bcl-2, displaces Bax and promotes cell death. Cell, 80, 285–291.
   PubMed Web of Science ®Google Scholar
• Kiefer, M. C., Brauer, M. J., Powers, V. C., Wu, J. J., Umansky, S. R., Tomei, L. D. and Barr, P. J. (1995). Modulation of apoptosis by the widely distributed bcl-2 homologue bak. Nature, 374, 736–739.
   PubMed Web of Science ®Google Scholar
• Chittenden, T., Harrington, E. A., O'Connor, R., Flemington, C., Lutz, R. J., Evan, G. I. and Guild, B. C. (1995). Induction of apoptosis by the Bcl-2 homologue Bak. Nature, 374, 733–736.
   PubMed Web of Science ®Google Scholar
• Delia, D., Aiello, A., Soligo, D., Fontanella, E., Melani, C., Pezella, F., Pierotti, M. A. and Porta, G. D. (1992). Bcl-2 protoncogene expression in normal and neoplastic human myeloid cells. Blood, 79, 1291–1298.
   PubMed Web of Science ®Google Scholar
• Naumovski, L. and Cleary, M. L. (1994). Bcl-2 inhibits apoptosis associated with terminal differentiation of HL-60 myeloid leukemia cells. Blood, 83, 2261–2267.
   PubMed Web of Science ®Google Scholar
• Park, J. R., Robertson, K., Hickstein, D. D., Tsai, S., Hockenbery, D. M. and Collins, S. J. (1994). Dysregulated bcl-2 expression inhibits apoptosis but not differentiation of retinoic acid-induced HL-60 granulocytes. Blood, 84, 440–445.
   PubMed Web of Science ®Google Scholar
• Huang, M. E., Ye, Y. C., Chen, S. R., Chai, J. R., Lu, J. X., Zhoa, L., Gu., H. T. and Wang, Z. Y. (1988). Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood, 72, 567–572.
   PubMed Web of Science ®Google Scholar
• Miller, W. H., Jakubowski, A., Tong, W. P., Miller, V. A., Rigas, J. R., Benedetti, F., Gill, G. M., Truglia, J. A., Ulm, E., Shirley, M. and Warrell, R. P. (1995). 9-cis retinoic acid induces complete remission but does not reverse clinically acquired retinoid resistance in acute promyelocytic leukemia. Blood, 85, 3021–3027.
   PubMed Web of Science ®Google Scholar
• Koeffler, H. P., Hirji, K., Itri, L. and Southern California Group (1985). 1,25-dihydroxyvitamin D3 in vitro and in vivo effects on human preleukemic and leukemic cells. Cancer Treat. Rep., 69, 1399–1407.
   PubMedGoogle Scholar
• Richard, C., Mazo, E., Cuadrado, M. A., Iriondo, A., Bello, C., Gandarillas, M. and Zubizarreta, A. (1986). Treatment of myelodysplastic syndrome with 1,25-dihydroxyvitamin D3. Am. J. Hemat., 23, 175–178.
   PubMed Web of Science ®Google Scholar
• Kelsey, S. M., Newland, A. C., Cunningham, J., Makin, H. L. J., Coldwell, R. D., Mills, M. J. and Grant, I. R. (1992). Sustained haematological response to high-dose oral alfacalcidol in patients with myelodysplastic syndromes. Lancet, 340, 316–317.
   PubMed Web of Science ®Google Scholar
• Colston, K. W., Mackay, A. G., James, S. Y., Binderup, L., Chander, S. and Coombes, R. C. (1992). EB1089: A new vitamin D analogue that inhibits the growth of breast cancer cells in vivo and in vitro. Biochem. Pharm., 44, 2273–2280.
   PubMed Web of Science ®Google Scholar
• Colston, K. W., Mackay, A. G. and James, S. Y. (1995). Vitamin D3 derivatives and breast cancer. In Ernst Schering Research Foundation Workshop 14: Apoptosis in Hormone-Dependent Cancer, edited by M. Tenniswood and H. Michna, pp. 201–224. Berlin, Heidelberg: Springer-Verlag.
   Google Scholar
• Simboli-Campbell, M., Narvaez, C. J., Tenniswood, M. and Welsh, J. (1996). 1,25-dihydroxyvitamin D3 induces morphological and biochemical markers of apoptosis in MCF-7 breast cancer cells. J. Steroid Biochem. Molec. Biol., 58, 367–376.
   PubMed Web of Science ®Google Scholar
• James, S. Y., Mackay, A. G. and Colston, K. W. (1995). Vitamin D derivatives in combination with 9-cis retinoic acid promote active cell death in breast cancer cells. J. Molec. Endo., 14, 391–394.
   PubMed Web of Science ®Google Scholar
• James, S. Y., Mackay, A. G. and Colston, K. W. (1996). Effects of 1,25 dihydroxyvitamin D3 and its analogues on induction of apoptosis in breast cancer cells. J. Steroid Biochem. Molec. Biol., 58, 395–410.
   PubMed Web of Science ®Google Scholar
• Elstner, E., Linker-Israeli, M., Said, J., Umiel, T., de Vos, S., Shintaku, I. P., Heber, D., Binderup, L., Uskokovic, M. and Koeffler, H. P. (1995). 20-epi-vitamin D3 analogues: a novel class of potent inhibitors of proliferation and inducers of differentiation of human breast cancer cell lines. Cancer Res., 55, 2822–2830.
   PubMed Web of Science ®Google Scholar
• Munker, R., Norman, A. and Koeffler, H. P. (1986). Vitamin D compounds. Effects on clonal proliferation and differentiation of human myeloid cells. J. Clin. Invest., 78, 424–430.
   PubMed Web of Science ®Google Scholar
• Elstner, E., Lee, Y. Y., Hashiya, M., Pakkala, S., Binderup, L., Norman, A. W., Okamura, W. H. and Koeffler, H. P. (1994). 1α, 25-dihydroxy-20-epi-vitamin D3: an extraordinarly potent inhibitor of leukemic cell growth in vitro. Blood, 84, 1960–1967.
   PubMed Web of Science ®Google Scholar
• Defacque, H., Dornand, J., Commes, T., Cabane, S., Sevilla, C. and Marti, J. (1994). Different combinations of retinoids and vitamin D3 analogues efficiently promote growth inhibition and differentiation of myelomonocytic leukaemia cell lines. J. Pharm. Exp. Therap., 271, 193–199.
   PubMed Web of Science ®Google Scholar
• Kliewer, S. A., Umesono, S. A., Mangelsdorf, D. F. and Evans, R. M. (1992). Retinoid X receptor interacts with nuclear receptors in retinoic acid, thyroid hormone and vitamin D signalling. Nature, 355, 446–449.
   PubMed Web of Science ®Google Scholar
• Schmid, I., Uittenbogaart, C. H., Keld, B. and Giorgi, J. V. (1994). A rapid method for measuring apoptosis and dual-color immunofluorescence by single laser flow cytometry. J. Immunol. Methods, 170, 145–157.
   PubMed Web of Science ®Google Scholar
• Philpott, N. J., Turner, A. J. C., Scopes, J., Westby, M., Marsh, J. C. W., Gordon-Smith, E. C., Dalgleish, A. G. and Gibson, F. M. (1996). The use of 7-amino actinomycin D in identifying apoptosis: simplicity of use and broad spectrum of application compared with other techniques. Blood, 87, 2244–2251.
   PubMed Web of Science ®Google Scholar
• Bradford, M. (1976). A rapid and sensitive method for the quantification of microgram quantities of protein utilising the principle of protein dye binding. Anal. Biochem., 72, 248–254.
   PubMed Web of Science ®Google Scholar
• James, S. Y., Williams, M. A., Kelsey, S. M., Newland, A. C. and Colston, K. W., (1997). Interaction of vitamin D derivatives and granulocyte-macrophage colony stimulating factor in leukaemic cell differentiation. Leukemia, 11, 1017–1025.
   PubMed Web of Science ®Google Scholar
• James, S. Y., Williams, M. A., Kelsey, S. M., Newland, A. C. and Colston, K. W. (1997). The role of vitamin D derivatives and retinoids in the differentiation of human leukaemia cells. Biochem. Pharm., in press.
   Google Scholar
• Thompson, C. B. (1995). Apoptosis in the pathogenesis and treatment of disease. Science, 267, 1456–1462.
   PubMed Web of Science ®Google Scholar
• Yin, X-M, Oltvai, Z. N. and Korsmeyer, S. J. (1994). BH1 and BH2 domains of bcl-2 are required for inhibition of apoptosis and heterodimerisation with bax. Nature, 369, 321–323.
   PubMed Web of Science ®Google Scholar
• Taimi, M., Chateau, M-T, Cabane, S. and Marti, J. (1991). Synergistic effect of retinoic acid and 1,25-dihydroxy-vitamin D3 on the differentiation of the human monocytic cell line U937. Leuk. Res., 15, 1145–1152.
   PubMed Web of Science ®Google Scholar
• Park, J. R., Bernstein, I. D. and Hockenbery, D. M. (1995). Primitive human hematopoietic precursors express bcl-x but not bcl-2. Blood, 86, 868–876.
   PubMed Web of Science ®Google Scholar
• Sanz, C., Benito, A., Silva, M., Albella, B., Richard, C., Segovia, J. C., Insunza, A., Bueren, J. A. and Fernández-Luna, J. L. (1997). The expression of bcl-x is downregulated during differentiation of human hematopoietrix progenitor cells along the granulocyte but not the monocyte/macrophage lineage. Blood, 89, 3199–3204.
   PubMed Web of Science ®Google Scholar
• Hockenbery, D. M., Zutter, M., Hickey, W., Nahm, M. and Korsmeyer, S. J. (1991). Bcl-2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc. Natl. Acad. Sci. USA, 88, 6961–6965.
   PubMed Web of Science ®Google Scholar
• Blagosklonny, M. V., Alvarez, M., Fojo, A. and Neckers, L. M. (1996). bcl-2 protein down-regulation is not required for differentiation of multidrug resistant HL-60 leukemia cells. Leuk. Res., 20, 101–107.
   PubMed Web of Science ®Google Scholar
• Xu, H-M, Tepper, C. G., Jones, J. B., Fernandez, C. E. and Studzinski, G. P. (1993). 1,25-Dihydroxyvitamin D3 protects HL-60 cells against apoptosis but down regulates the expression of the bcl-2 gene. Exp. Cell Res., 209, 367–374.
   PubMed Web of Science ®Google Scholar
• Brown, G., Bunce, C. M., Rowlands, D. C. and Williams, G. R. (1994). All-trans retinoic acid and lα, 25-dihydroxyvitamin D3 co-operate to promote differentiation of the human promyeloid leukaemia cell line HL-60 to monocytes. Leukemia, 8, 806–815.
   PubMed Web of Science ®Google Scholar
• Wallington, L. A., Bunce, C. M., Durham, J. and Brown, G. (1995). Particular combinations of signals, by retinoic acid and 1α, 25-Dihydroxyvitamin D3, promote apoptosis of HL-60 cells. Leukemia, 9, 1185–1190.
   PubMed Web of Science ®Google Scholar
• Elstner, E., Linker-Israeli, M., Umiel, T., Le, J., Grillier, I., Said, J., Shintaku, I. P., Krajewski, S., Reed, J. C., Binderup, L. and Koeffler, H. P. (1996). Combination of potent 20-epi-vitamin D3 analogue (KH1060). with 9-cis-retinoic acid irreversibly inhibits clonal growth, decreases bcl-2 expression, and induces apoptosis in HL-6 leukemic cells. Cancer Res., 56, 3570–3576.
   PubMed Web of Science ®Google Scholar
• Elstner, E., Linker-Israeli, M., Le, J., Umiel, T., Michl, P., Said, J. W., Binderup, L., Reed, J. C. and Koeffler, H. P. (1997). Synergistic decrease of clonal proliferation, induction of differentiation, and apoptosis of acute promyelocytic leukemia cells after combined treatment with novel 20-epi vitamin D3 analogs and 9-cis retinoic acid. J. Clin. Invest., 99, 349–360.
   PubMed Web of Science ®Google Scholar
• Evans, R. M. (1988). The steroid and thyroid hormone receptor superfamily. Science, 240, 889–895.
   PubMed Web of Science ®Google Scholar
• Collins, S. J., Robertson, K. A. and Mueller, L. (1990). Retinoic acid-induced granulocytic differentiation of HL-60 myeloid leukemia cells is mediated directly through the retinoic acid receptor (RAR-α). Mol. Cell. Biol., 10, 2154–2163.
   PubMed Web of Science ®Google Scholar
• Dawson, M. I., Elstner, E., Kizaki, M., Chen, D-L, Pakkala, S., Kerner, B. and Koeffler, H. P. (1994). Myeloid differentiation mediated through retinoic acid receptor/retinoic X receptor (RXR) not RXR/RXR pathway. Blood, 84, 446–452.
   PubMed Web of Science ®Google Scholar
• Nagy, L., Thomázy, V. A., Shipley, G. L., Fésüs, L., Lamph, W., Heyman, R. A., Chandraratna, R. A. S. and Davies, P. J. A. (1995). Activation of retinoid X receptors induces apoptosis in HL-60 cell lines. Mol. Cell Biol., 15, 3540–3551.
   PubMed Web of Science ®Google Scholar
• Mehta, K., McQueen, T., Neamati, N., Collins, S. and Andreeff, M. (1996). Activation of retinoid receptors RARα and RXRα, induces differentiation and apoptosis, respectively, in HL-60 cells. Cell Growth Diff., 7, 179–186.
   PubMedGoogle Scholar
• Agarwal, N. and Mehta, K. (1997). Possible involvement of bcl-2 pathway in retinoid X receptor alpha induced apoptosis of HL-60 cells. Biochem. Biophys. Res. Commun., 230, 251–253.
   PubMed Web of Science ®Google Scholar
• Defacque, H., Commes, T., Legouffe, E., Sevilla, C., Rossi., J. F., Rochette-Egly, C. and Marti, J. (1996). Expression of retinoid X receptor α is increased upon monocytic cell differentiation. Biochem. Biophys. Res. Commun., 220, 315–322.
   PubMed Web of Science ®Google Scholar